MAPT and Alzheimer disease: The mechanism for the initiation of hyperphosphorylation of these tau proteins is not known; however, the deposition of Aβ fragments has been suggested to act as an upstream pathophysiological event triggering other AD-associated pathogenic events especially the NFTs.